Google- Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ran - IBD Reporter Newsfeed - IBD Support Group Forums - IBDsupport.org

Advertisement

Jump to content


Photo
- - - - -

Google- Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ran

Started By Health Reporter , Oct 05 2020 05:46 PM

  • Please log in to reply
No replies to this topic

#1 Health Reporter

Health Reporter

    Newsfeeder

  • RSS
  • PipPipPipPip
  • 22938 posts
  • Country:United States

Posted 05 October 2020 - 05:46 PM

Advertisement

Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial The Lancet

 

View the full article



Advertisement
Back to IBD Reporter Newsfeed



© Copyright 1995-2014 IBD Support All rights reserved.

About Us | Contact Us | Advertise With Us | Disclaimer | Terms of Service | Crisis Resources

This website is certified by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here


  1. IBD Support Group Forums - IBDsupport.org
  2. → Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis
  3. → IBD Reporter Newsfeed
 
Terms of Use
Copyright
Privacy Policy